Details of the Drug
General Information of Drug (ID: DMKYE16)
Drug Name |
1,3-Diethyl-3,7-dihydro-purine-2,6-dione
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
1,3-Diethylxanthine; SC 2079; 5169-95-9; 1,3-diethyl-3,9-dihydro-1h-purine-2,6-dione; CHEMBL416013; UNII-4550Q64O79; 4550Q64O79; 1,3-Diethylxantine; Xanthine,3-diethyl-; NSC 515479; 1,3-diethyl-xanthine; AC1L2QSV; AC1Q6LGQ; 1,3-diethyl-1H-purine-2,6(3H,7H)-dione; SCHEMBL515564; BDBM82021; CTK8I9744; CTK8D7769; DTXSID40199644; 1H-Purine-2,6-dione, 1,3-diethyl-3,7-dihydro- (9CI); GIMNFISWKTZFKJ-UHFFFAOYSA-N; Xanthine, 1,3-diethyl- (8CI); NSC515479; 1,3-diethyl-7H-purine-2,6-dione; AKOS030616954; NSC_101420; NSC-515479; CAS_101420
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 208.22 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.9 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||||||||